News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
ZymoGenetics, Inc. Says Court Denies King Pharmaceuticals®, Inc. Motion; Court Dismisses all Motions on Trademark Suit
December 11, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters - ZymoGenetics Inc (ZGEN.O) said a U.S. district court denied all of King Pharmaceuticals Inc's (KG.N) motions for preliminary injunction in a trademark violation suit.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Regulatory
MORE ON THIS TOPIC
Job Trends
8 Companies Hiring Now in Regulatory
October 23, 2025
·
2 min read
·
Angela Gabriel
Drug pricing
Trump To Target Trading Partners With Drug Pricing Probe: Report
October 22, 2025
·
1 min read
·
Annalee Armstrong
Podcast
Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn
October 22, 2025
·
1 min read
·
Heather McKenzie
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
October 21, 2025
·
2 min read
·
Dan Samorodnitsky